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1. Introduction 
 
1.1 Prevention of infections after intraocular surgery 
 
Most postoperative ocular infections (i.e. endophthalmitis) are caused by the patient’s 
own normal flora.10;11;90 These infections are rare, severe and arise from any kind of surgical 
procedure that disrupts the integrity of the ocular globe (i.e. cataract surgeries, radial 
keratotomy, retinal surgeries and glaucoma filtering surgeries).54 The worst of these infections 
is a postoperative endophthalmitis (POE): a severe infectious inflammation involving the 
anterior and posterior segments of the eye, with severe visual loss in 30 %, and blindness in 
18 % of the patients (Fig. 1).71;97;98 
 
The best preoperative prophylaxis has yet not been found. Several studies have been 
conducted to reduce preoperative bacterial load on the conjunctiva. Antiseptics like povidone-
iodine (PVI) lower preoperative bacteria and decrease incidence of POE. Flushing of 
conjunctival fornices with PVI alone is considered as the best proven prophylaxis before 
intraocular surgery.7;14;89 Also, antibiotics appear to play an important role in decreasing 
bacterial load before surgery.48 Different antibiotics have been studied in combination with 
PVI.9 Nevertheless, the antibiotic susceptibility of bacteria changes; as a consequence there 
are high levels of resistance to most of the antibiotics previously studied (i.e. Neosporin, 
norfloxacin, tobramycin, ciprofloxacin).46;83 Because of low corneal penetration, most 
antibiotics studied do not achieve satisfactory intraocular levels.24;30;37;69;79 . Last-generation 
fluoroquinolones have much lower rates of bacterial resistance than ofloxacin and 
ciprofloxacin, and a delayed propensity to development of resistance.61 Levofloxacin (third 
generation fluoroquinolone) has a high corneal penetration rate when used topically and 
reaches excellent intraocular levels.98 Though fluoroquinolones and PVI lower conjunctival 
bacterial load4;59;66, no study has compared their effect to patients treated with PVI alone. In 
the Department of Ophthalmology at the University of Munich the only prophylaxis before 
intraocular surgery was soaking of the orbital skin with 10% Povidone-iodine and flushing of 
the conjunctiva with 10 ml 1% povidone-iodine. 
 2
 
Figure 1. POE after a pars plana vitrectomy; 
Clinical appearance: surgical wound, inflamed 
conjunctiva, hypopyon and corneal edema. 
 
Incidence of POE: 
 
The incidence of postoperative endophthalmitis is reported to be around 0.07 to 0.3 %, 
as reported in the last 20 years. There are some differences in the observed rates between 
different authors and countries (Table 1).87  
 
Table 1. Incidence of POE in the last 21 years.  
 
Study   Place   Period   Incidence (%) 
Aaberg, et al.1  USA   1984-1994  0.093 
Kattan, et al.52 USA   1984-1989  0.072 
Colleaux, et al.26 Canada  1994-1998  0.072 
Versteegh, et al.94 Netherlands  1988-1998  0.10 
Fisch, Salvanet.35 France   1988-1989  0.31 
Mayer, et al.81  UK   1991-2001  0.16 
Kamalarajah, et al.50 UK   1999-2000  0.14 
Semmens, et al.82 Australia  1980-2000  0.18 
Sandvig, et al.80 Norway  1996-1998  0.10 
Schmitz, et al.81 Germany  1996   0.148 
Montan, et al.70 Sweden  1998   0.26 
Nagaki ,et al.72 Japan   1998-2001  0.13 
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1.2 Role of the conjunctival normal flora 
Normal conjunctival flora: 
The bacterial flora of untreated human conjunctiva has shown various growth patterns 
from conjunctival samples between different studies and authors16;33;91. The results of 
bacterial growth from conjunctival swabs show a predominant presence of coagulase-negative 
staphylococci (CNS): i.e. Staphylococcus epidermidis (Table 2). Less frequent bacteria are 
S. aureus, microaerophilic bacteria (i.e. Corynebacterium sp), Streptococcus sp. and Gram-
negative rods (i.e. E. coli, Pseudomonas  aeruginosa). 
 
Table 2. Found bacteria in cultures from healthy conjunctivas. 
 
Bacteria   Fahmy, 1975  Boes, 1992  Starr, 1995 
Coag. neg. staphylococci 95.4 %   60 %   58 % 
Staphylococcus aureus 14.8 %   8 %   7 % 
Streptococcus sp  4.4 %   4 %   1 % 
Gram-negative rods  * 7.8 %   4 %   5 % 
Anaerobics **   44 %   12 %   2 % 
Others ***   3 %   0 %   3 % 
Sterile    0 %   25 %   24 % 
Patients (N)   N = 499  N = 100  N = 1000 
 
* Pseudomonas aeruginosa, Haemophilus influenzae, E. coli, Proteus sp., Klebsiella sp., Enterobacter cloacae; 
** Propionibacterium. acnes, Corynebacterium sp., Clostridium sp., Peptostreptococcus sp.;  
***  mixed of Gram- positive, Gram-negative, and anaerobic bacteria. 
 
 
Bacteria in postoperative endophthalmitis: 
 
Bacteria causing postoperative endophthalmitis most likely originate from the normal 
bacterial flora of the patient's own conjunctiva and eyelid10;90. In 75 % to 95 % of reported 
cases, the causative organisms are gram-positive cocci. As described by the Endophthalmitis 
Vitrectomy Study11, varieties of coagulase-negative staphylococci (CNS) are the main causes 
of acute endophthalmitis43 (Table 3). 
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Table 3. Result of cultures from postoperative endophthalmitis43. 
 
Percentage  Etiology 
70 % Staphylococcus epidermidis and other coagulase negative staphylococci 
(CNS) 
24 %                        Staphylococcus aureus 
6 %   Gram-negative rods 
< 1 % Other, i.e.: Propionibacterium  acnes, Pseudomona aeruginosa, 
Haemophilus  influenzae. 
 
 
Less frequently, acute endophthalmitis is caused by streptococci and Gram-negative 
rods. Anaerobic or microaerophilic organisms such as Propionibacterium acnes are more 
commonly found in chronic and late intraocular inflammations14;45 (table 3). Because gram-
positive cocci are the main cause of acute POE, methods intended to reduce conjunctival 
bacterial flora should be effective against these bacteria. 
 
Large prospective studies evaluating the effectiveness of prophylactic methods to 
reduce POE are not feasible due to its low incidence. However as an alternative, surrogate 
markers such as the reduction of preoperative conjunctival bacterial flora are usually applied 
to demonstrate the efficacy of prophylactic measures.7;14;15;48;66;67;89 
 
1.3 Alternatives for the prevention of postoperative infections 
 
Strategies preventing postoperative infections begin with the adoption of usual 
prophylactic measures like providing a sterile operative field, strict hospital policies regarding 
the prevention of nosocomial infections, and scrubbing of the periorbital skin with povidone-
iodine.  
 
Alternatives for the prevention of postoperative infections after intraocular surgery are 
summarized in Table 4. Many methods have failed to give convincing evidence of their utility 
and/or safety: mechanical techniques (i.e. saline irrigation, lash trimming), subconjunctival 
antibiotics and irrigating solutions with added drugs (i.e. heparin or antibiotics). Conjunctival 
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flushing with povidone-iodine (PVI) and topically applied antibiotics have proved to be safe 
and effective in reducing the bacterial load before intraocular surgery87. 
 
Table 4. Summary of prophylactic methods in postoperative endophthalmitis. 
 
Prophylactic  
Method Result Practicality 
Saline  
irrigation No evidence supporting its use. Easy to perform. 
Lash 
Trimming No evidence supporting its use. 
Impractical and  
uncomfortable. 
Subconjunctival 
antibiotics 
Evidence supporting a positive reduction in POE, there remains however  
a lack of standardized reports supported by epidemiologic studies,  
and the concern about the toxic effects has not been cleared. Most proposed 
subconjunctival antibiotics are not the best option to reduce 
Gram-positive cocci (main cause of POE). 
Invasive. Increases 
cost. 
Risk of traumatic 
complications. 
Heparin in  
irrigating 
solution 
Uncertain. Increased cost  and time. Invasive. 
Irrigating  
solutions 
containing 
antibiotics 
Aminoglycosides: Severely toxic to the retina.  
Vancomycin: Small and limited studies suggest utility; not supported by 
epidemiological studies. Since the active threshold of the intraocular 
 concentration of antibiotics is rather short, microbiological experience  
discourages their use.  
 
Increased cost  
and time. Invasive. 
Topical 
preoperative 
antibiotics 
Probed diminished infectivity of the conjunctiva. Fluoroquinolones have  
high ocular penetration and a wide bacterial spectrum, including  
Gram-positive cocci. There are no current standards that apply to  
the combination of fluroquionolones with povidone-iodine flushing. 
Easy and relatively 
low cost.  
Non-invasive. 
Povidone- 
iodine flushing Best proved prophylaxis, in both clinical and epidemiological studies. 
Easy and low cost. 
Non-invasive. 
 
 
Mechanical preoperative techniques: 
 
The most frequently used mechanical preoperative techniques are for example 
irrigation with saline solutions and the trimming of eyelashes: 
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• Saline irrigation: Active flushing of the conjunctival sacs with an isotonic saline fluid 
(saline irrigation) is performed before intraocular surgery. A masked prospective study 
demonstrated that irrigation with a saline solution did not reduce the bacterial flora of 
the conjunctiva compared with unirrigated fellow control eyes.48 A non-infected 
lacrimal system does not appear to play an important role in the contamination as 
shown in a large prospective study of 700 consecutive patients undergoing planned 
cataract extraction. Preoperative irrigation of the lacrimal system with balance salt 
solution did not significantly influence intraoperative aqueous humor contamination 
rates.69 In a German survey, saline irrigation was not associated with a reduction in the 
incidence of endophthalmitis.81 
 
• Lash trimming: Some surgeons cut the edges of the lashes before intraocular surgery. 
There are no studies demonstrating that lash trimming reduces the risk of 
endophthalmitis.81 One study of 50 patients undergoing cataract extraction confirmed 
that lash trimming before surgery did not alter the periocular bacterial flora present on 
the morning of surgery and at any time during the first four postoperative days.74  
 
Subconjunctival antibiotics: 
 
The injection of subconjunctival antibiotics was one of the first prophylactic methods 
proposed when using antibiotics87. Subconjunctival antibiotics have an apparent effect on 
human conjunctival flora as well as in animal models for the prevention of postoperative 
infections.2;30;32;84 Nevertheless, epidemiological data is scarce. Studied agents are from the 
cephalosporin group (i.e. cephaxolin and ceftazidime), chloramphenicol and gentamicin 
sulfate. One masked study compared subconjunctival cephazolin with preoperative topical 
antibiotics (1 % fusidic acid and chloramphenicol).30 Quantitative bacterial counts from the 
conjunctiva and lash lines of each patient 24 hours before, on the morning of, and 48 hours 
after surgery showed significant reductions of the ocular microflora in the group that received 
subconjunctival cephazolin, compared with those who received preoperative topical 
antibiotics. There are no similar studies comparing subconjunctival antibiotics with topical 3 rd 
and 4th generation fluoroquinolones. 
 
Aminoglycosides (gentamicin) were considered useful based on animal models.2 
Apparently, an antimicrobial prophylaxis of 20 mg subconjunctival gentamicin sulfate at the 
 7
time of surgery significantly reduced the incidence of postoperative bacterial endophthalmitis 
in aphakic rabbits exposed to S. aureus.2 A similar result has been observed after using the 
same antibiotic regimen in a rabbit model.32 In another animal endophthalmitis model 
subconjunctival ceftazidime was used successfully.84 Sub-Tenon's administration of 
gentamicin failed to prevent endophthalmitis as opposed to an intravitreal injection of 30 µg 
gentamicin.75 
 
In the German broad epidemiological survey from Schmitz et al, administration of 
subconjunctival antibiotics at the end of surgery was not associated with reduced incidence of 
endophthalmitis, while representing potential surgical and toxic risks.81  
 
Irrigating solutions with added drugs: 
 
During intraocular surgical procedures, isotonic irrigating solutions are used. Some 
surgeons add drugs to these irrigation fluids as another alternative to prevent postoperative 
infections. 
 
• Irrigating solutions with added heparin: In vitro studies show that heparin lowers 
bacterial adhesion to the surface of artificial intraocular lenses used in cataract 
surgery. Studies evaluating aqueous contamination rates with heparin show mixed 
results. Apparently, heparin reduces adhesivity of S. epidermidis, S. aureus, and P. 
aeruginosa.77 There is a discussion that heparin may reduce adherence by placing a 
highly hydrated layer between the bacteria and the IOL surface.77 However, a 
randomized, double-masked, controlled study showed no significant difference in the 
rate of culture-positive anterior chamber aspirates between the heparinized group and 
the control group (31 % vs. 27 %, respectively).62 
 
Irrigating solutions with added antibiotics: This is the most controversial preventive 
method in ophthalmology. Some studies have supported its use81. Potential toxic effects to 
corneal endothelial cells should not be ignored.18;21;22;27-29;65 Other authors claim that the 
effect of antibiotics in the irrigation solution may be ultimately ephemeral because the half 
life of any antibiotic is achieved approximately two hours after surgery.42;57 Aminoglycosides 
and vancomycin are the ones most frequently used. 
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Aminoglycosides: An Indian study in 1976 demonstrated the effectiveness of 
intraocular gentamicin in irrigation solutions to prevent postoperative infections76, 
compared to topical and systemic chloramphenicol.76 This was also confirmed by 
another study in 1984.38 Nowadays, preventive intraocular Aminoglycosides are not 
used due to the evidence of their toxicity.18;21;22;27-29;31;65 
 
Vancomycin: This antibiotic is used to treat infective endophthalmitis. It has a 
low retinal toxicity, and as a result, many authors used it in irrigating solutions with 
some rate of success (sterile intraocular fluids after surgery and low inflammation 
rate) in animal and in vitro models.3;12 Unfortunately, clinical protocols in patients 
under cataract surgery failed to support this hypothesis and thus discourage its use.58;59 
The antibiotic is used only during the procedure. As a result, bacteria have a short 
exposure time to the drug. A microbiological model proved that, with the short 
exposure time to the antibiotic, there is little effect on the organisms commonly 
responsible for endophthalmitis.42 Other studies showed low maintenance of 
bactericidal levels.57  
 
 
1.4 Povidone-Iodine (PVI) 
 
PVI is a strong antiseptic with minimal secondary effects (i.e. red eye, allergic 
reactions) in healthy conjunctivas.7;14;89 It is applied in concentrations of 1 – 5 % by directly 
flushing of the upper and lower fornices of the conjunctiva before an intraocular procedure 
(Fig. 2). 
 
In 1984, Apt and Isenberg 7 described a chemical preparation using povidone-iodine 
before cataract surgery. In this masked prospective study 30 consecutive patients undergoing 
eye surgery showed that povidone-iodine (Betadine) dilutions decreased numbers of colonies 
by 91 % and decreased the numbers of species by 50 % when treated with PVI. These 
findings were statistically significant compared to the untreated fellow control eyes.7 
 
A large German survey indicated a significant reduction in the relative risk of 
postoperative endophthalmitis for the application of povidone-iodine on the conjunctiva.81 
Another group of investigators conducted a large open-label nonrandomized parallel trial 
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during an 11-month period, in which topical 5 % povidone-iodine was used preoperatively in 
one set of five operating rooms, whereas silver protein solution was applied in another set of 
five rooms.89 In all cases, surgeons continued to use their customary prophylactic antibiotic. 
The patients with povidone-iodine showed a significantly (P < 0.03) lower incidence of 
culture-positive endophthalmitis, compared with the silver protein group. There were no 
adverse reactions to povidone-iodine. 
 
In a large prospective controlled trial Speaker and Menikoff found evidence for an 
association between prophylaxis with povidone-iodine and lower incidence of postoperative 
endophthalmitis.88;89 This is the biggest prospective study correlating a prophylactic measure 
with the ultimate outcome parameter: postoperative endophthalmitis. 
 
The ability of povidone-iodine preparation to decrease the conjunctival flora has been 
confirmed in several other studies.14;15;45;55 Povidone-iodine preparation decreases the 
conjunctival load of Propionibacterium acnes, a common cause of chronic postoperative 
endophthalmitis.14;45 In one study of 488 patients undergoing cataract extraction, povidone-
iodine solution decreased the incidence of P. acnes isolation from the conjunctiva from 
36.7 % to 9 %.45 In another study with 261 patients undergoing intraocular surgery, 60 of 261 
conjunctival swabs (23 %) taken after application of antibiotic eye drops 
(polymyxin/B sulfate, neomycin sulfate, and gramicidin in combination) but before povidone-  
 
 
Figure 2. Flushing of upper and lower fornices  
with PVI. 
 
iodine application were positive for P. acnes. After povidone-iodine treatment, five (1.9 %) 
remained culture positive (P < 0.001).14 A similar study by the same group demonstrated a 
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similarly beneficial effect with respect to staphylococci, the most common causative bacteria 
of endophthalmitis.15 
 
Povidone-iodine is a strong chemical antiseptic. It can be applied to the conjunctiva 
prior to any ocular incision. It cannot be used as a postoperative agent because of risks of 
intraocular leak. In animal models by Alp, Elibol et al corneal edema was observed in all eyes 
of groups who received even minor quantities of intraocular povidone-iodine.6 In the same 
study, minimal amounts of intraocular povidone-iodine did not significantly change the 
endothelial cell morphology and the mean endothelial cell count. There was no significant 
difference in corneal thickness between groups without povidone-iodine and those with only 
minimal amounts, however toxicity effects occurred at higher intraocular concentrations. 
Nevertheless, histopathological examination by transmission and scanning electron 
microscopy showed corneal changes even in those eyes with minimal amounts of intraocular 
povidone-iodine.6 
 
When povidone-iodine is used in preparing the eye for intraocular surgery and as an 
alternative to postoperative antibiotics, inadvertent leakage of PVI into the anterior chamber 
must definitely be prevented.6 Despite the potential problems discussed, it is unlikely that 
preoperative treatment with povidone-iodine would leak into the anterior chamber. The reason 
is that all excess fluid is dried before making the first incision. 
 
Given in a concentration of 1% in a study by Binder et al, PVI treatment significantly 
reduced conjunctival colonization.15 Ferguson, in a comparative study, found a concentration 
of 5 % more effective than a 1% concentration of PVI.34 But the studies are not comparable, 
because the former applied 10 ml flushing and the latter 2 ml. A newer report on application 
of PVI proved a conjunctival irrigation with 10 ml of 5 % povidone-iodine to be more 
effective in reducing the bacterial load on the conjunctiva compared to the same concentration 
dosis given in two eye drops.67 
 
 
 
 
 
 
 11
1.5 Topical preoperative antibiotics 
 
When considering the option of adding an antibiotic to the PVI prophylaxis, many 
ophthalmologists give topical antibiotics before surgery81;85. Topical preoperative antibiotics 
should decrease the ocular surface flora that may potentially enter the anterior chamber during 
surgery. In addition, some topical agents, especially fluoroquinolones, can penetrate the 
cornea to achieve effective concentrations in the anterior chamber.44 
 
In contrast to the experience with the PVI prophylaxis, there are no broad 
epidemiological studies showing that the adoption and use of antibiotics after a major surgery 
would reduce the incidence of endophthalmitis. The use of antibiotics to prevent intraocular 
infections has been promoted, but consistent antibiotic use is still not a routine practice in all 
centers. There is a paucity of literature evaluating the effect of topical antibiotics on the 
incidence of postoperative infections. Prospective, randomized clinical and bacteriological 
studies evaluating the effect of topical antibiotics on the bacterial conjunctiva flora have been 
also conducted. 
 
Because of their broad spectrum and good corneal penetration, topical 
fluoroquinolones are interesting in the prevention of endophthalmitis. The next sections will 
focus on topical antibiotic prophylaxis with drugs other than fluoroquinolones, followed by 
fluoroquinolones themselves. 
 
1.5.1 Topical antibiotics: Other than fluoroquinolones 
 
Most of them have been shown effective in reducing conjunctival bacterial load before 
intraocular surgery, but it has not been consistently proven that they reduce the intraocular 
fluid contamination. Some have high rates of resistance amongst infective bacteria. Thus, 
several studies evaluating anterior chamber aspirates have not demonstrated any significant 
effect of these antibiotics on intraocular levels of bacteria after surgery.24;30;37;69;79 A study 
examined the vitreous fluid obtained during pars plana vitrectomy in 40 consecutive patients 
undergoing pars plana vitrectomy and who where randomly assigned to receive either 0.3 % 
gentamicin eye drops or placebo preoperatively.37 There were less bacterial growth from the 
vitreous of patients who received gentamicin preoperatively. Additionally, in a large 
prospective study of 700 consecutive patients undergoing planned cataract extraction, anterior 
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chamber aspirates were shown to be culture-positive in 14.1% at the beginning and in 13.7 % 
at the end of surgery. Preoperative treatment with neomycin did not significantly influence 
intraoperative aqueous humor contamination rates.69 
 
One multicentered open-label study evaluated the effect of a one day course of topical 
tobramycin on the preoperative conjunctival smears of 313 asymptomatic patients before 
cataract surgery. Eleven coagulase-negative staphylococci (CNS) sensitive to tobramycin 
persisted in 41 of 110 patients (37.3 %) and S. aureus sensitive to tobramycin persisted in 4 of 
30 patients (13.3 %). Newly acquired potentially pathogenic bacteria were demonstrated in 6 
of 115 (5.2 %) previously negative and 22 of 198 (11 %) previously positive conjunctival 
cultures. Each of the gram-negative bacteria could be eliminated by a one day treatment of 
topical prophylaxis with tobramycin eye drops and ointment in this study. The authors note 
that the estimated statistically determined elimination rate also supported the potential role of 
topical tobramycin in prophylaxis.13 Nevertheless, tobramycin does not have the capability to 
penetrate the cornea and reach the therapeutic levels found in treatment with 
fluoroquinolones.44 
 
 Topical antibiotics other than fluoroquinolones plus PVI in POE prophylaxis  
 
Only few studies related to topical antibiotics stressed the potentially additive role of 
antibiotics in combination with povidone-iodine for the reducing of the bacterial conjunctival 
flora before intraocular surgery.9;48 In one study topical Neosporin ophthalmic solution given 
three times daily was compared with topical povidone-iodine in the fellow eye for 3 days 
preoperatively.48 When used independently, the antibiotic and povidone-iodine solutions 
caused a similar decrease in the number of colonies and species of bacteria cultured from the 
ocular surface. Used together both regimens showed that the decrease was more pronounced, 
with 83 % of the conjunctival swabs showing no bacterial growth.48 In a similar study, the 
authors compared the out-patient use of povidone-iodine for 3 days before surgery with a 3-
day course of a combination neosporin ophthalmic solution placed on the other eye. Cultures 
taken just before the preparation of the operative field with povidone-iodine showed a similar 
reduction of bacteria by each regimen. Cultures taken after preparation with povidone-iodine 
showed a further reduction for both regimens, but this was even more pronounced in eyes 
previously treated with the antibiotic (P < 0.02).9 Another study suggested that preoperative 
topical gentamicin (1 drop each hour for 10 hours) and povidone-iodine showed a similar 
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decrease in ocular surface flora.60 Another group described a placebo-controlled, randomized, 
double-blind clinical trial evaluating the efficacy of patient-administered 1 % fusidic acid 
viscous eye drops (4 times per day for 7 days) in clearing S. epidermidis and S. aureus from 
the lids and conjunctiva of 79 patients before cataract surgery.40 There was a statistically 
significant reduction of bacteria isolated from the lid margins and the conjunctiva in the 
patients treated with antibiotics.40 
 
 
1.5.2 Topic antibiotics: Fluoroquinolones 
 
The emerging resistance toward the main causative agents of postoperative endophthalmitis 
(coagulase negative staphylococci) to the previously used preoperative topical antibiotics 
prompted the use of other substances. It is thought that broad systemic use of these antibiotics 
caused the resistances to arise, and not the topical use.46;83 The main benefit of 
fluoroquinolones are that they inhibit bacterial replication. The two main bacterial enzymes 
targeted by the fluoroquinolones are the topoisomerase II (also known as DNA gyrase) and 
topoisomerase IV.47 The activity of newer fluoroquinolones against both Gram-positive and 
Gram-negative bacteria and their good corneal penetration are convincing arguments for 
promoting their use. 
 
 Antecedents 
 
In the 1990's, three topical fluoroquinolones were available for topical ophthalmic use 
in the United States: 0.3 % ciprofloxacin, 0.3 % ofloxacin, and 0.3 % norfloxacin. 
Norfloxacin (0.3%) never achieved widespread use due to its relatively poor antimicrobial 
activity. Both 0.3 % ciprofloxacin and 0.3 % ofloxacin were rapidly adopted for the treatment 
and prophylaxis of ocular infections. In fact, they are still used for the treatment of self-
limited external eye infections such as bacterial conjunctivitis as well as more serious 
infections such as bacterial keratitis.56;73;85;95 However, to date no randomized clinical trials 
have been performed in an attempt to investigate the epidemiological role of these topical 
antibiotics prior to ophthalmic surgery.59 
 
In the last ten years, an increasing tendency to adopt the use of topical 
fluoroquinolones for prevention of postoperative infections has been noted. Because of the 
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newly registered resistance described, bacterial coverage became an issue worthy of 
consideration regarding antibiotic prophylaxis and agent selection. An emergence of 
resistance has been noted among gram-positive organisms because of excessive systemic use 
of fluoroquinolones, traditionally chosen for topical prophylaxis because of their broad 
spectrum of activity.4;39 In addition, there are also reports of resistance to fluoroquinolones 
among Gram-negative organisms.23 
 
 Ocular penetration 
 
As we know, fluoroquinolones are capable of penetrating the cornea enabling them to 
achieve significant intraocular concentrations sufficient enough to suppress the replication of 
infective pathogens that might contaminate the eye at the end of the surgery.44 Because of 
resistance, the use of fluoroquinolones of third (levofloxacin) and fourth-generation 
(moxifloxacin and gatifloxacin) has been suggested. Fourth-generation fluoroquinolones have 
a high spectrum of activity with increased penetration into ocular tissues.61 Levofloxacin (a 
third-generation fluoroquinolone), with high-activity against gram-positive pathogens47, offers 
the highest penetration of all fluoroquinolones.98  
 
 Time of prophylaxis 
 
To reach intraocular therapeutic levels fluoroquinolones require a specific time to 
penetrate the cornea and conjunctiva. There are two recent prospective randomized studies. 
One compared the administration of topical ofloxacin 1 hour before surgery with 
administration 4 times daily for 3 days before surgery. The results suggested that the longer 
the regimen was applied, the higher its efficacy in decreasing surface contamination and 
intraocular activity.93 In this study, 42 % of eyes in the 1-hour group showed positive 
conjunctival culture immediately before surgery, compared with 19 % of eyes in the 3-day 
group. Immediately after surgery, 34 % and 14 % of eyes had positive cultures in the 1-hour 
and 3-day group respectively. Quantitatively, fewer bacteria were isolated from eyes in the 3-
day group compared to those in the 1-hour group.36 Another study by the same group 
evaluated the contamination rate of microsurgical knives during cataract surgery, comparing 
the 3-day with the 1-hour preoperative application of topical ofloxacin. The results showed 
that 26 % of knives in the 1-hour group were positive for bacterial growth compared with 
only 5 % in the 3-day group.66 
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 Resistance 
 
Although fluoroquinolones have traditionally been chosen for topical prophylaxis 
because of their broad spectrum of activity against bacterial pathogens, resistance has been 
emerging to this class of antibacterials, particularly among Gram-positive organisms.39 An 
increase of resistance to ciprofloxacin and ofloxacin was noted from 1993 to 1997 amongst 
S. aureus, coagulase-negative staphylococci, and Streptococcus species, approaching 50 % of 
isolates examined in some cases.39 Another study in South Florida reported a three-fold 
increase in resistance to fluoroquinolones amongst S. aureus isolates4, and there are also 
reports of resistance to fluoroquinolones amongst Gram-negative organisms.23 
 
Resistances among older fluoroquinolones have been attributed to inappropriate 
sublethal dosing in systemic treatments.59 Besides the third-generation fluoroquinolones (i.e. 
levofloxacin), the fourth-generation fluoroquinolones, such as gatifloxacin and moxifloxacin, 
offer a possible alternative in an area of emerging resistance. These agents confer a dual-
binding mechanism of action in gram-positive organisms, inhibiting both DNA gyrase and 
topoisomerase IV, which is believed to expand their spectrum of activity to inhibit bacterial 
strains otherwise resistant to older fluoroquinolones.36;64 Recently they have been confirmed 
to show higher efficacy against preoperative multiresistant isolates.68  
 
 
1.5.3 Levofloxacin 
 
The third and fourth generation fluoroquinolones available in the United States for 
topical ophthalmic use are: levofloxacin 0.5 % (third generation), gatifloxacin 0.3 %, and 
moxifloxacin 0.5 % (fourth generation). The main advantage of these compounds is their 
similar strong gram-positive activity compared to older fluoroquinolones, like ciprofloxacin 
and ofloxacin.61 Additionally, other discussed and potentially beneficial features shared by 
some of these antibiotics include enhanced drug delivery into the anterior segment, improved 
activity against certain strains of atypical mycobacterium, and lowered likelihood of selection 
for resistant bacterial strains.44 
 
Moxifloxacin and gatifloxacin offer improved spectrum of activity, increased 
penetration into ocular tissues and delayed propensity to the development of bacterial 
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antibiotic resistance.61 Nevertheless, levofloxacin has higher activity against gram-positive 
pathogens47, and has shown high intraocular penetration after topical application.98 
 
1.6 Combination of povidone-iodine and levofloxacin 
 
Certain measures and precautions can be taken in order to reduce the risk of 
postoperative intraocular infections. These include applying topical povidone-iodine to 
orbicular skin, avoiding vigorous irrigation and sealing marginal wounds postoperatively. For 
technical reasons and concerning controversial risks (Table 4) the use of subconjunctival or 
intraocular antibiotics is discouraged by most ophthalmologists. There is the possibility of 
combining povidone-iodine flushing with effective topical antibiotics which can penetrate the 
cornea and reach excellent intraocular levels (i.e. levofloxacin).44;61 
 
The combination of topical antibiotic and prophylaxis with PVI flushing has been 
studied. Many studies using antibiotics (neosporin, gentamicin, fusidic acid, polymyxin/B, 
neomycin sulfate and gramicidin) showed the additive role they play with PVI 
prophylaxis.9;14;40;48;60 Posterior studies proved the resistance of coagulase-negative 
staphylococci to these commonly used preventive antibiotics, and prompted the use of 
fluoroquinolones.47;66;67 
 
The use of topical antibiotics such as fluoroquinolones may also be beneficial in 
preventing postoperative intraocular infections.4;39;44 Its postoperative use should begin 1-3 
days prior to surgery, and frequent dosage immediately postoperatively is recommended. 67 
The newer third and fourth-generation fluoroquinolones are good agents with high 
bactericidal levels, which may help in addressing the emerging resistance.23;39 
 
Use of preoperative conjunctival povidone-iodine preparation is strongly supported 
whether prophylactic antibiotics are used or not.66;67 In order to decrease the conjunctival flora 
of patients prior to intraocular surgery, we can combine PVI and a fluoroquinolone.66;67 
Nevertheless, there is no prospective and randomized study comparing patients treated with 
PVI alone against an added fluoroquinolone. Given the alarming resistance patterns, it is 
suggested that a broad-spectrum, highly permeable antibiotic with low toxicity like 
levofloxacin should be studied.47;61;98 
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1.7. Purpose of the Study 
 
The purpose of this study is to evaluate the effect of combining topical 0.5% 
levofloxacin (four times per day, one day prior to intraocular surgery) plus conjunctival 
flushing with 10 ml 1 % povidone-iodine (PVI), versus the effect of 10 ml 1% PVI flushing 
alone on the conjunctival bacterial flora. 
 
Justification: To the best of our knowledge, there is no prospective and randomized 
study that compares the use of combined levofloxacin and PVI with simple PVI irrigation, in 
order to reduce the amount of bacterial conjunctival flora in patients scheduled for intraocular 
surgery. Povidone-iodine prophylaxis is considered the most justified prophylactic measure to 
reduce the amount of bacteria prior to intraocular surgery. 9;14;15;67;88-90;25 The advantages of 
levofloxacin are its low secondary effects, its high capability amongst topical 
fluoroquinolones to reach effective levels in the anterior chamber, and its excellent 
antibacterial spectrum.53  
 
The incidence of infections after intraocular surgery is very low; as a result in analogy 
to reported experience7;14;15;48;66;67;89, culture positivity of preoperative conjunctival swabs is 
used as a surrogate marker to evaluate these new prophylactic methods. 
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2. Material and methods 
 
2.1 Design 
 
The study was designed as a prospective and randomized trial. 
 
2.2 Ethics 
 
This is a study conducted with voluntary patients to evaluate preoperative conjunctival 
bacterial reduction after combining povidone-iodine (PVI) and levofloxacin, compared to PVI 
alone. This third-generation fluoroquinolone with a broad spectrum and low collateral effects 
is frequently used for lid and conjunctival infections and also after intraocular 
surgeries.4;39;56;73;85 
 
This study was conducted according to the World Medical Association Declaration of 
Helsinki 96, under the Policy of “Ethical Principles for Medical Research Involving Human 
Subjects”, adopted by the 18th WMA General Assembly, Helsinki, Finland, June 1964. On 
this basis, we first asked the patients for authorization to use an extra medicine in addition to 
standardized povidone-iodine prophylaxis. Smears were taken from the conjunctiva with a 
moistened swab. This could cause discomfort and theoretically has a low risk of minor 
adverse effects such as small conjunctival hematoma or minor corneal excoriation. 
 
Patients scheduled for intraocular surgery with planned anterior chamber incision or 
paracentesis were asked to participate in the study. Patients were over 18 years old. All 
patients that agreed to participate in the study were asked to sign a letter of consent before 
being recruited. 
 
An application was submitted to the Ethics Commission of the Institutional Review 
Board at Ludwig-Maximilians-University for study approval (in German: Ethikkommission 
der Medizinischen Fakultät der Ludwig Maximilians Universität München). The research was 
approved by the Ethics Commission on September 28th, 2004, as Project Nr. 230/04, under the 
official German title: 
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"Effekt von topisch appliziertem 0,5 %-igem Levofloxacin auf die bakterielle 
Standflora der Bindehaut als Infektionsprophylaxe bei Patienten vor intraokularem 
Eingriff". 
 
The act was signed by Prof. Dr. G. Paumgartner, Chairman of the Ethic Commission. 
The main person responsible for the project was Dr. rer. nat. Herminia Miño de Kaspar. 
 
 
2.3 Patient characteristics 
 
Participants were recruited from patients attending control or first-time appointments. 
They were referred to the out-patient clinic and planned for intraocular surgery, i.e. cataract 
surgery. The study was conducted in the Department of Ophthalmology at the University of 
Munich (Augenklinik der Ludwig-Maximilians-Universität, München), with recruitment 
initiated in November 2004 and completed in May 2005. 
 
The design included a control group and a study group. Both groups received the 
standard prophylactic 10 ml povidone-iodine 1 % conjunctival flushing, while only the study 
group received an extra prophylactic therapy with antibiotics, 24 hours before surgery. Each 
group was planned to include 70 patients. 
 
Patients were recruited, randomized and followed at the same time. The demographic 
characteristics were designed to be the comparable. They were randomly assigned to either 
study or control group. 
 
 
 Inclusion criteria: 
 
• Selection was made from patients attending for the first time, or as a follow up 
date. The gender was irrelevant. 
 
• The patients programmed for elective intraocular anterior chamber surgery were 
invited to participate in the study. There were no patients included with active 
systemic or local infection. Three different types of surgeries were classified: 
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1. Cataract surgery with intraocular lens implantation: the most frequent 
intraocular operation. 
2. Cataract surgery with intraocular lens implantation and pars plana vitrectomy: 
a frequent combination of surgery at this clinic. 
3. Other elective intraocular procedures of the anterior chamber: glaucoma 
surgery, penetrating keratoplasty, intraocular lens malposition, iridoplasty, 
etc. 
 
• Each patient had to fully understand the characteristics and objectives of the study 
and to sign a consent letter. 
 
 Exclusion criteria: 
 
• Patients who reported allergy to fluoroquinolones, iodine, some of the additional 
pupil- dilating eye drops or preservative agents in eye drops (i.e. benzalkonium 
chloride). 
 
• Patients who had received a systemically or locally administered antibiotic within 
the previous 30 days. 
 
• Patients with acute conjunctivitis, blepharitis or dacryocystitis. 
 
• Patients under the age of 18 years. 
 
• Patients who were not able to understand the characteristics and objectives of this 
investigation. 
 
 
 Method of randomization 
 
At the beginning of the study, a list with 140 numbers was elaborated. The Microsoft-
Office-Excel software program (Microsoft, Inc., Seattle, USA) was used to generate random 
numbers that were assigned to each group. The patients were randomized to either a control or 
study group. This randomization was distributed in sealed envelopes. Patients learned about 
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their group assignment from their treating ophthalmologist, who opened the envelope and 
explained the specific preoperative prophylactic regimen. 
 
In order to compare similarity between both groups; demographic data such as age, 
sex, eye operated (right or left) and type of conducted surgery were registered. 
 
 
 Prophylaxis in the groups 
 
a) Prophylaxis in all patients in control and study groups 
 
All patients were treated as in-patients. Handling before surgery was identical. Patients 
were instructed not to use the medication on their fellow eye. Patients under antibacterial 
treatment were excluded from the study. One hour before the surgery, the patients in both 
groups received the standard eye drops employed to dilate the pupil: three doses of 
proxymetacaine hydrochloride 0.5 % and three doses of phenylephrine-hydrochloride 5 %. 
This was done after acquisition of the second conjunctival swab (see details in the following). 
 
For all patients in both groups the brow, upper and lower eyelids, eyelashes, and 
adjacent forehead, nose, cheek, and temporal orbital area were scrubbed with 10 % povidone-  
 
 
Figure 3. Orbital skin scrubbed with 10% PVI. 
 
iodine (PVI, Braunol®, Ratiopharm GmbH, Ulm, Germany) for 1 minute before 
surgery(Fig. 3). Gauze soaked with 10 % PVI was placed on the closed eye for 5 minutes after 
the patient was brought into the operating room (Fig. 4). Immediately before starting surgery, 
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the conjunctiva of the surgical eye, regardless of the assigned group, had a flushing with 
10 ml 1 % PVI solution through the upper and lower fornices (Fig. 5). All excess fluid with 
PVI was dried up, the surgical field was draped in a sterile fashion, and a sterile lid speculum 
was then placed in the eye undergoing surgery (Fig. 6). After that, the surgery was performed 
according to the indicated procedure. 
 
 
 
Figure 4. Gauze soaked with 10% PVI placed 
on the closed eye for 5 minutes. 
 
 
 
 
Figure 5. Before starting surgery, upper and  
lower fornices are flushed with 10ml 1%  
PVI solution. 
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b) Added prophylaxis for study group only  
 
Eyes scheduled for surgery of patients in the study group received one drop of 0.5 % 
levofloxacin eye drops (Oftaquix®, Santen Oy, Tampere, Finland) 4 times a day into the 
conjunctival sac on the day prior to surgery and 3 applications of one drop each beginning 
1 hour prior to surgery in 5 minute intervals. These drops were administered by nurses. 
 
 
Figure 6. Surgical field is draped in a sterile  
fashion, and a sterile lid speculum is set in  
place. 
 
 
2.4 Bacteria 
 
 Time points at which conjunctival smears for culture were acquired 
 
Four smears of conjunctiva for the cultures were taken from each eye, at three specific 
time points prior to surgery, and one after the operation (Table 5). Time point T0 is at baseline 
1 day before surgery, when patients were accepted for hospitalization, T1 refers to smears 
taken after one day of administration of topical levofloxacin for the study group, T2 and T3 
represent samples obtained after iodine application. The times T0 and T1 correspond to 
samples taken before the patient entered the operating theater. The samples T2 and T3 were 
performed in the operating room, immediately before and after the operation. 
 
The sample T1 was taken in the morning on the day of surgery. This sample had to be 
taken in both groups before application of topical mydriatic and vasoconstrictor, and at less 10 
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hours since the last application of the antibiotic in the study group. For patients of the study 
group, this T1 sample was taken before application of the day-of-surgery dose of 
levofloxacin. The T2-sample was done with lid speculum in position, 5 minutes after iodine 
flushing. And T3 was done at the end of surgery, before the surgeon removed the lid 
speculum. 
 
Table 5. Time points at which conjunctival smears to be cultivated were obtained 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Taking and pursuit of the cultures 
 
The technique of taking a conjunctival smear is a simple procedure, but needs to be 
performed with care. Each sample must be taken using the same methodology in order to 
obtain an equivalent amount. Only one moistened cotton swab was used at each time point 
(BD-BBL™ Culture Swab™ EZ, Collection and Transport System, from Becton, Dickinson 
and Company, Sparks, MD Inc., USA). Collection of specimen was performed by completely 
rotating this cotton swab through the lower conjunctival sac from the temporal to the medial 
fornix in order to pick up specimens of all its surface parts. Special care was taken: 
 
• Not to contact lid margins and lashes. 
 
• Not to depress the fornix as this causes slight pain and an excessive sample. 
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• Not to touch the cornea as this causes slight pain in addition to the minimum risk 
of corneal excoriation. 
 
The person in charge of taking the samples T0 and T1 from the control and study cases 
was the same person using the same technique with the identical material. At T0 and T1, 
cultures were obtained without topical anaesthetic to optimize bacterial growth by eliminating 
any preservative that might affect bacterial growth. The persons that obtained the conjunctival 
cultures at T0 and T1, as well as the surgeons (Fig. 7) that obtained the culture samples at T2 
and T3, were masked as to whether the patient was in the control or study group. 
 
 
Figure 7. With the patient dressed in sterile  
sheets, the surgeon took the T2 sample and  
can initiate the surgical procedure. 
 
 
 
Figure 8. After taking the culture the probe  
is cut to 3 cm from its base and the swab is  
deposited in a liquid culture. 
 
All probes were managed in a sterile fashion and cut 3 cm from their base with 
sterilized scissors (Fig. 8). The cotton tip was then put into thioglycolate broth. All cultures 
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were incubated at 37 °C for at least 10 days, and bacterial growth was identified. The swab 
with the cut handle was dropped in a liquid broth in a glass recipient (9 ml of Thioglycolate + 
Réazurine, bioMérieux®, Marcy L'Etoile, France). The randomized number, the culture code 
number, and the name initials of the patients were written onto the glass recipient of the 
culture media with a permanent marker (Fig. 9) in order to ensure trace ability. During 
observation of these cultures, the growth control was carried out. 
 
 
Figure 9. The cultures were incubated for 10  
days. 
 
The cultures were left to incubate at 37 °C (Memmert® Incubator, Thyssen), and 
observed for 10 days (Fig. 10). The thioglycolate culture was considered to be of “positive 
growth” if the broth was cloudy within 10 days of incubation, and  “sterile”, if after 10 days 
the medium maintained its clear and citrine transparent color. The decision of when to take a 
culture out of the incubator was dependent on the growth of bacteria. The bacterial growth 
was graded according to the volume of the liquid medium that was occupied by visible 
bacterial growth (Fig. 10). Colony growth patterns were graded from one cross (+), indicating 
barely visible small colonies, to three crosses (+++), where at least 2/3 of the medium was 
occupied by bacterial growth. In case of diffuse bacterial growth, the criteria ranged from 
slight opacity (+) to impossibility to see the finger holding the glass recipient behind the 
medium (+++). When positive growth of (++) or more was observed, positivity of growth was 
registered and bacteria were identified. If after the 10 days, a positivity of one + was found, 
the culture was considered positive and the bacteria identified. 
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Figure 10. Incubation of the swabs in thio- 
glycolate broth for 10 days.  
 (Note: The cannula cultivated in the second tube  
corresponds to another parallel investigation) 
 
 
The persons responsible for the management and registration of positive cultures 
obtained from the patients' conjunctivas did not know whether the cultures under surveillance 
came from the control or the study group. The microbiologist responsible for isolating and 
identifying the bacteria was also masked as to the patients' group assignment. 
 
Identification of coagulase-negative staphylococci was done by the same person 
performing the direct biomicroscopy and enzymatic coagulase test. The resistance to 
levofloxacin was registered via the Kirby-Bauer disc-diffusion technique. 
 
The primary criteria for the outcome of this study were the measurement of positive or 
negative growth in cultures, as found in the thioglycolate broth. Although isolated bacteria 
were identified and tested for antibiotic susceptibility, a broader examination of bacterial 
susceptibilities to antibiotics will be presented as the main theme of another parallel medical 
doctoral dissertation. Nevertheless, this study presents the results related to the presence of 
Gram-positive bacteria, specially coagulase-negative staphylococci (the main cause of 
postoperative intraocular infections) and its resistance to levofloxacin (the antibiotic studied 
in this thesis). 
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2.5 Statistics 
 
 Demographics 
 
To demonstrate that both groups are comparable, a demographic statistical analysis of 
the distribution related to gender, age, eye operated and intraocular procedures indicated for 
each group was performed. The method used to study these variables was the non-parametric 
distribution test of Wilcoxon-Mann-Whitney U (Software: BiAS®-2006 for Windows). 
 
 Hypothesis 
 
Null hypothesis (H0): There is no difference in the reduction of positive bacterial growth 
from the cultures of conjunctival swabs in patients prior to the intraocular surgery if treatment 
with levofloxacin 0.5 % 1 day before the procedure is added to the 10 ml 1% povidone-iodine 
conjunctival flushing. 
 
Alternative hypothesis (H1): There is a greater reduction in positive bacterial growth of 
conjunctival cultures taken from patients prior to surgery who were treated with levofloxacin 
0.5 % 1 day before intraocular surgery and a preoperative conjunctival flushing with10 ml 1% 
povidone-iodine flushing. 
 
 
 Method used to validate alternative hypothesis 
 
Modified Fisher Exact Test, one-tailed p-value calculation (Software: BiAS®-2006 for 
Windows). 
 
Results of positive or negative bacterial growth from cultured conjunctival swabs in 
both groups were obtained at different time points. Contingency tables comparing both groups 
at three time points before surgery (T0, T1 and T2) and one after surgery (T3) were produced. 
These tables are “2 X 2” type, suitable for a Fisher's Exact Test. If the variables are 
controlled, we can use a modified Fisher exact test in order to increase precision. The 
statistical comparison with a focus on the differences in positive bacterial growth in the 
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thioglycolate broth at time points T0 and T2 for the control and study group was the main 
source of validation for our alternative hypothesis. 
 
We compared two prophylactic methods that reduce conjunctival flora. The controlled 
variable was an added antibiotic in the study group. In both groups, flushing with 10 ml 1% 
PVI was performed. As a result, we expected a reduction of bacterial growth in both groups. 
A two-tailed Fisher test is recommended only when the observer does not know which 
direction will occur in the research (greater or lesser presence of bacteria). A one-tailed test 
considers the expected lowering of bacteria in both groups and evaluates the hypothetical 
enhanced reducing effect of levofloxacin. 
 
Simple size for each group was set to 70. Experience from earlier investigations 
implicated an estimate rate of positive cultures in thioglycolate broth at T1 to be around 90% 
in the untreated control and around 70% in the treated study group. With a given significance 
level of 0.05 and a predetermined power of at least 85%, needed sample size was calculated to 
be at least 65. Because lost to follow up was expected to be not more than 10%, sample size 
for each group was set to 70. 
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3. Results 
 
3.1 Patient characteristics (Table 6) 
 
The eyes of one hundred and thirty four patients scheduled to undergo anterior 
chamber surgery were enrolled in the study from November 2004 to May 2005 at the 
Department of Ophthalmology of the Ludwig-Maximilians-University in Munich, Germany. 
Patients were randomly assigned to control and study group (n = 70 each). Data acquisition 
was incomplete in 9 cases (6%). This was due to missed conjunctival swabs in three patients, 
two in the control group and one in the study group. The reasons were lack of availability of 
the person collecting the swab in one case, and re-scheduled surgery in two cases. In an 
additional two cases in the study group and one in the control group patients violated study 
protocol and were excluded. They had used antibiotic drugs other than study medication. 
Three more patients (one in study and two in control group) withdrew from study 
participation. All these nine cases with incomplete data were excluded from statistical 
evaluation. Analysis of the dropout rate between the control and study groups revealed no 
statistically significant difference (P = 0.730). As a consequence 131 of 140 patients were 
evaluated, comprising 66 eyes in the study group and 65 eyes in the control group (Table 6).  
 
Table 6. Demographic data in control and study groups. 
 
Age in years Gender Operated eye Type of surgery 
 
Median (range) Mean M F RE LE CE/IOL CE/IOL + PPV 
Other 
IOAC 
Study group 
n = 66 69 (25 – 90) 67.2 ± 14.5 22 44 33 33 50 11 5 
Control 
group 
n = 65 
71 (23 – 87) 68.6 ± 12.5 25 40 31 34 50 5 10 
Total 
n = 131 70 (23 – 90) 67.9 ± 13.5 47 84 64 67 100 16 15 
Statistical 
distribution P = 0.689 P = 0.587 P = 0.792 P = 0.914 
 
M = males; F = females; RE = right eye; LE = left eye; CE/IOL = cataract extraction with intraocular lens 
implantation; CE/IOL + PPV = combined cataract extraction with intraocular lens implantation and pars plana 
vitrectomy; other IOAC = other intraocular anterior chamber procedures 
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No local ocular or systemic adverse reaction were observed in the patients, either after 
the preoperative topical application of 0.5% levofloxacin in the study group patients, or after 
the flushing with 10 ml 1% povidone-iodine in both, control and study groups. 
 
There were 84 females and 47 males; the median age of all patients was 70 years 
(range 23-90 years) with a mean of 67.9 ± 13.5 years. In total, 64 right eyes and 67 left eyes 
were operated. This included cataract surgery with intraocular lens implantation (n = 100), 
combined cataract extraction with intraocular lens implantation and pars plana vitrectomy 
(n = 16), and other intraocular anterior chamber procedures (n = 15). Statistical analysis of the 
distribution of these criteria revealed no significant differences between the study and control 
group (age P ≥ 0.689; gender P ≥ 0.587; operated eye P ≥ 0.792; type of surgery P ≥ 0.914). 
Demographic details and statistical distribution related to each variable is shown in table 5. 
Both groups are non-parametrically distributed and are comparable (Table 6). 
 
3.2 Bacteria 
  
Positive cultures (Table 7) 
 
Table 7. Results of positive bacterial cultures. 
 
T0 T1 T2 T3 
 
Study Control Study Control Study Control Study Control
Total eyes (n = 131) 66 65 66 65 66 65 66 65 
Cultures taken (n = 524) 66 65 66 65 66 65 66 65 
Positive cultures 55 54 50 60 8 20 5 15 
Sterile cultures 11 11 16 5 58 45 61 50 
Proportion of 
positive cultures 0.837 0.831 0.758 0.923 0.121 0.308 0.076 0.231 
Proportion of 
sterile cultures 0.166 0.169 0.242 0.077 0.879 0.692 0.924 0.769 
Statistical distribution 
(p value) P = 0.969* P = 0.009** P = 0.008** P = 0.012** 
The proportion of positive cultures in both groups at the beginning of the study (T0) is similar (P = 0.969).  
There is a difference in the proportion of positive cultures between both groups time points T1, T2 and T3 (P =  
0.009, 0.008 and 0.012 respectively)* Two-tailed Fisher Exact test; ** One-tailed Fisher Exact Test 
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During the study, 524 conjunctival swabs were taken from 131 eyes to be cultured in 
the same numbers of thioglycolate broth (Table 7).  
 
Positive results of cultures grown in thioglycolate broth from eyes in both groups are 
shown in table 7. The baseline culture results (T0) showed no statistically significant 
difference between groups concerning the spectrum of cultured bacteria in thioglycolate broth 
(P = 0.969). 54 of 65 samples in the control group (83.1 %) had positive cultures, similar to 
55 of 66 eyes (83.7 %) in the study group (P = 0.969). 
 
On the day of surgery, after one day of topical levofloxacin for the study eyes (T1), 60 
of 65 eyes (92.3 %) in the control group without topical antibiotic showed positive cultures, 
compared with 50 of 66 eyes (75.8 %) in the study group with topical antibiotic (P = 0.009). 
The percentage of positive cultures at T0 increased from 83.1 % to 92.3 % at T1 in the control 
group’s eyes and decreased from 83.7 % at T0 to 75.8 % at T1 in the study group’s eyes. This 
change did not reach statistically significant levels in either the control or the study group (P 
= 0.181 and P = 0.388 respectively, Fig. 11) 
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Figure 11: Percentage of positive growth in control and study groups at the four study 
time points. * P  < 0.05 
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Immediately before surgery at T2 (5 minutes after flushing with PVI), 20 of 65 eyes 
(30.8 %) in the control group had positive cultures, compared with only 8 of 66 eyes (12.1 %) 
in the study group (P = 0.008). The change in the percentage of positive cultures from T1 to 
T2 was 92.3 % to 30.8 % in the control group (P < 0.001) and 75.8 % to 12.1 % in the study 
group (P < 0.001). At this time point, there was a high reduction of positive growth in both 
groups, which was statistically significantly more pronounced in the study group (P = 0.008) 
(Figure 11). 
 
At T3, 15 of 65 eyes (23.1 %) in the control group and 5 of 66 eyes (7.6 %) in the 
study group had positive cultures (P = 0.012). Figure 11 shows the identified number of 
positive cultures in both control and study group at the four time points of conjunctival 
smears. 
 
Identified bacteria (Table 8) 
 
Table 8 shows the identified bacteria in both control and study group at the four time 
points of conjunctival smears. In some cases mixed cultures occurred, total amount are higher 
compared to culture positive results from conjunctival swabs (Table 7). 
 
Throughout each time point, there was a progressive reduction of the total amount of 
identified bacteria in the study group, from 63 in T0 to 50 and 8 in time points T1 and T2. The 
control group showed an important reduction only at time point T1 to T2 (62 to 22). By time 
point T2, just before starting surgery the total amount of identified bacteria in the control and 
study groups was 22 and 8 respectively. The control group had 2.75 times more bacteria than 
the study group. 
 
The most commonly isolated bacteria in both groups through T0 to T3 were 
coagulase-negative staphylococci (CNS); 82 of the 124 (66 %) isolated bacteria were CNS; 40 
and 42 strains in the control and study group respectively at the beginning of the study at T0. 
The numbers decreased at T1 to 39 and 37 in both the control and the study group. The most 
important reduction took place after the PVI flushing, with 15 and 8 strains of CNS in the 
control and study group respectively. By time point T2, before starting surgery, the study 
group, who received levofloxacin prophylaxis, had a 53 % lower presence of CNS than the 
control group.  
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Both groups had presence of S. aureus, with 5 and 6 strains at T0 in the control and 
study group respectively. At time point T2, before starting the surgery, no S. aureus was 
detected in the study group and one strain could be found in the control group. 
 
Table 8. Isolated bacteria from conjunctival swabs in thioglycolate broth. 
 
T0 T1 T2 T3 
 
Control Study Control Study Control Study Control Study 
Coagulase-neg. 
staphylococci 40 42 39 37 15 8 14 4 
Staphylococcus aureus 5 6 6 4 1 0 1 0 
α-haemolytic 
Streptococcus 1 2 2 1 1 0 0 0 
β-haemolytic 
Streptococcus 3 2 3 1 1 0 0 0 
Streptococcus group D 1 0 1 0 0 0 0 0 
Corynebacterium sp 3 3 3 2 0 0 0 0 
Propionibacterium sp 5 6 6 4 3 0 0 1 
Micrococcus sp 0 0 0 0 0 0 0 0 
Pseudomonas sp 1 1 0 0 0 0 0 0 
Other gram-negative 
Bacteria 2 1 2 1 1 0 2 0 
Total amount of 
identified bacteria 61 63 62 50 22 8 17 5 
 
 (The numbers indicate the amount of bacteria identified) 
 
Other identified bacteria were α-haemolytic Streptococcus, β-haemolytic 
Streptococcus, Streptococcus Group D, Corynebacterium sp, Propionibacterium sp, 
Micrococcus sp, Pseudomonas sp, and other Gram-negative Bacteria. At time point T2, just 
before surgery, the control group had 15 strains of CNS and 7 strains of bacteria other than 
CNS, including 3 strains of Propionibacterium sp. In contrast, at time point T2, the study 
group did not show growth of any bacteria other than the 8 strains of CNS. 
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 Levofloxacin susceptibility (Table 9) 
 
During the study, bacteria cultured in thioglycolate broth were identified and isolated. 
Antibiotic susceptibilities of the identified strains of CNS and S. aureus were evaluated 
(Table 9). These bacteria are those most frequently found in postoperative infections43. 
 
At the beginning of the study, at time point T0 for study and control groups, a total of 
93 strains of staphylococci (CNS and S. aureus), were isolated. Amounts were similar, with 
45 strains in the control and 48 in the study group. By time point T0, 82 of the isolated 
bacteria were susceptible to levofloxacin (88.2 %). Four (4.3 %) were intermediate-
susceptible and 6 (6.4 %) were resistant. At time point T0 each group showed three strains of 
staphylococci resistant to levofloxacin. At time point T1, those three strains of resistant 
bacteria were again isolated in each group. The number of resistant organisms in both groups 
were reduced after the povidone-iodine flushing (time point T2) to one strain of CNS resistant 
to levofloxacin in the control group and two in the study group. At time point T3 there were 
still 15 strains of staphylococci in the control group and only 4 in the study group (all 
susceptible or intermediate-susceptible to levofloxacin). At T3, at the end of surgery, no 
bacteria resistant to levofloxacin could be isolated. 
 
Table 9. Susceptibility of isolated staphylococci to levofloxacin in study and control 
group at the time points of the study. 
 
T0 T1 T2 T3 
 
Control Study Control Study Control Study Control Study 
CNS 40 42 39 37 15 8 14 4 
S. aureus 5 6 6 4 1 0 1 0 
Total 45 48 45 41 16 8 15 4 
Susceptible 41 42 40 36 15 5 14 3 
Intermediate 1 3 2 2 0 1 1 1 
Resistant 3 3 3 3 1 2 0 0 
(CNS = Coagulase negative staphylococci) 
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4. Discussion 
 
One of the goals in the prevention of infections after intraocular surgery is to reduce 
the number of eyelid and conjunctival bacteria that are present at the time of surgery. The 
source of bacteria causing postoperative endophthalmitis is thought to be the patient’s own 
conjunctiva.10;90 In an attempt to minimize the risk of endophthalmitis, prophylactic measures 
are used to reduce the amount of bacteria in the surgical field. The topical administration of 
antibiotics is preferred. It has been shown that preoperative application of both topical 
povidone-iodine and various antibiotic agents are effective in reducing the incidence of 
contamination as measured by the growth of bacterial colonies in conjunctival 
isolates7;9;14;15;19;41;48;86 Many cataract surgeons place their patients on topical antibiotic 
therapy in the preoperative period. Many also use intraoperative subconjunctival injections 
2;30;32;84 or intraocular infusions of antibiotics.59;63 Reports about toxicity of subconjunctival 
injections, and the associated risks have discouraged their use.81 The use of irrigating 
solutions containing antibiotics is likewise attended by much controversy.18;21;22;27-29  
 
In our study we did not find local or systemic collateral effects related to the use of the 
povidone-iodine flushing or the 0.5% levofloxacin prophylaxis. The optimal characteristic of 
topical antibiotics used for preoperative endophthalmitis prophylaxis includes the ability to: 
kill bacteria, highly permeable, bioavailability, low toxicity, broad-spectrum coverage, 
particularly for gram-positive bacteria and favorable susceptibility patterns. Antibiotics given 
before, during and after surgery can potentially reduce the ocular bacterial load. This is 
particularly important given the prevalence of antibiotic resistance that has resulted from 
widespread and prolonged use of systemic antimicrobial agents.9;13;30;40;48 Fluoroquinolones 
whose best trait are their ability to reach effective levels in the anterior segment have been 
shown to be one of the best options.4;39;44;59;66;67 It is important to characterize ocular bacterial 
flora and to determine their antibiotic susceptibility patterns in patients undergoing intraocular 
surgery. 
 
One potential weakness of our study is that bacterial conjunctival flora must be 
regarded as a “dynamic” rather than a static factor, and are therefore subject to changes over 
time. This could result in different amounts and species detected at various time points. 
Though we tried to minimize the time period between the first two swabs to two days, one 
could argue that results at T1 as compared to T0 could have been influenced by such changes. 
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We would expect an equal distribution of the results in both test groups if this hypothesis 
were to hold true. Secondly, as long as no active inflammation is present, these changes 
should be minor and not relevant to the outcome of this research. 
 
In our study the patients in the control group did not receive a placebo in the form of 
eye drops. One might argue that results at T1 in patients of the study group could have been 
caused by dilutive effects through the application of fluid alone. This is unlikely because there 
was not application of eyes drops ten hours before the conjunctival probing of eyes under the 
levofloxacin prophylaxis was done. As a result the tear was not markedly disturbed and the 
antimicrobial effect of levofloxacin was observed. Additionally, in a study by Isenberg et al., 
irrigation of the conjunctiva with saline solutions alone did not reduce the bacterial flora of 
the conjunctiva compared to unirrigated fellow control eyes.48 In a later study the same group 
found that irrigation of the conjunctiva with saline actually tended to increase the ocular 
flora8. As a result, it is commonly accepted that conjunctival bacteria flora are not 
significantly influenced by application of doses of fluid alone, and earlier studies evaluating 
the effect of topical antibiotic treatment were conducted without use of a placebo.9;36;39;60;66;67 
 
4.1 Prophylactic methods and proportion of positive cultures 
 
Povidone-iodine (PVI) 
 
The major reduction in the number of positive growth of bacteria in cultures from both 
groups with or without the antibiotic was observed after the 10 ml 1% PVI flushing 
prophylaxis (P < 0.05), but the effect was even more pronounced in eyes of the study group 
treated with levofloxacin (P = 0.009). The most widely accepted method for preoperative 
prophylaxis is still povidone-iodine flushing.7;14;15;45;55;88-90 In a review of the literature, Ciulla 
et al found PVI to have the highest evidence concerning prevention of endophthalmitis.25 
Schmitz et al. reported decreased rates of intraocular infection among those surgeons using 
povidone-iodine as preoperative prophylaxis.81 
 
Isenberg et al compared bacterial growth from conjunctival swabs after a prophylactic 
regimen comprised of one or two drops of 5 % PVI with or without a three-day application of 
neomycin sulphate, polymyxin B sulphate and gramicidin given three times a day.48 In their 
study, which included both eyes of 35 consecutive patients, the authors found the combination 
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of both antibiotic and povidone-iodine to be highly effective in reducing the bacterial 
conjunctival load. Combining PVI with antibiotics has been suggested to decrease the 
presence of bacteria after intraocular surgery. 
 
Antibiotic and PVI 
 
Topical antibiotics and iodine are used in the preoperative period to minimize the 
number of bacteria on the ocular surface.47;66;67;87;91 In this study, positive growth of bacterial 
cultures from conjunctival swabs in patients before intraocular surgery was used as a 
surrogate marker to compare prophylactic methods. After one day prophylaxis with 0.5% 
levofloxacin (time point T1), there were fewer positive cultures in the patients with topical 
antibiotic (P = 0.009). The results imply that topical levofloxacin significantly reduced the 
number of bacteria present on the ocular surface compared to the omission of the antibiotic. 
 
However the combination of topical levofloxacin and iodine was more effective in 
reducing bacteria from the ocular surface just before intraocular anterior chamber surgery 
compared to iodine alone (P = 0.008). The effect is maintained until the end of surgery, as 
observed at T3 (P = 0.012). Both T2 and T3 are the most critical points, given that they 
represent the time immediately before and after surgery, a window of opportunity for the 
bacteria to gain entry into the eye.  
 
In our design the control group did not receive any preoperative antibiotic, only the 
preoperative PVI irrigation, in order to evaluate additional effect of antibiotic treatment. On 
the morning of the surgery, patients with no prophylactic method had 92% of positive cultures 
(T1 control group). Those patients treated with the antibiotic as their only prophylaxis showed 
76% of positive cultures (T1 study group). After povidone-iodine flushing alone we found 
only 31% of positive cultures (T2 control group). The strongest reduction of bacterial growth 
from conjunctival swabs was observed after the combined prophylaxis of levofloxacin and 
PVI flushing, with 12% of the cultures with positive growth (T2 study group); 2.5 times lower 
than with povidone-iodine flushing alone. In 1985, the study of Isenberg et al48 observed the 
effect on the conjunctiva of 3 ml 5% povidone-iodine and a combination of prophylactic 
antibiotics (neomycin sulphate, polymyxin B sulphate and gramicidin) and they found 17% of 
positive cultures. The results of that study would be difficult to replicate due to the reported 
changes in  resistance patterns of bacteria to old antibiotics.9;13;30;40;48 
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In 2002 Ta et al, a study design very similar to this work, it had been shown that 
preoperative treatment with topical 0.3% ofloxacin reduced the bacterial load on the 
conjunctiva.93 Contrary to our study, both the control and study groups received antibiotics, 
but for different time periods; one hour before surgery or four times a day for a three-day 
period previous to anterior chamber operation. After one hour of antibiotic prophylaxis and 10 
ml 1% PVI flushing, there were a 34% of positive cultures in thioglycolate broth. The 
combination of three days 0.3 % ofloxacin therapy and 10 ml 1% PVI flushing showed 14% 
of positive cultures. 
 
For the sake of comparison, Table 10 has been created to highlight the results of our 
study, Isenberg48 and Ta,93 however studies from different universes are not comparable. Ta 
used a fluoroquinolone (ofloxacin) for three days before intraocular surgery, and the positivity 
of cultures of 14% was similar to our percentage of 12% with only one day of levofloxacin 
prophylaxis. Only a prospective study comparing different regimens of levofloxacin therapy 
would prove whether a three day term of levofloxacin prophylaxis before intraocular surgery 
would be a better option. 
 
Though our study does not provide evidence of whether additional topical treatment 
with levofloxacin further decreases incidence of endophthalmitis, it can be hypothesized that 
reduced amounts of bacteria within the surgical area lower the chances of contamination. 
 
Table 10. Percentage of positive cultures before surgery. 
 
Prophylactic method 
 
Source 
 
Percentage of 
Positive 
Cultures 
No prophylaxis 
Present study.  
T1 control group 92% 
Levofloxacin 0.5 %  
4 x 1 day 
Present study.  
T1 study group 76% 
Ofloxacin 0.3 % 1 hr before surgery  
+ 10 ml 1% PVI 
Ta et al,93 
2002 34% 
10 ml 1% PVI  
flushing alone 
Present Study.  
T2 control group 31% 
Neomycin sulphate-polymyxin B sulphate-
gramicidin + 3 ml 5% PVI 
Isenberg et al,48  
1985 17% 
Ofloxacin 0.3 % 4 x 3 days  
+ 10 ml 1% PVI 
Ta et al,93 
2002 14% 
Levofloxacin 0.5 % 4 x 1 day  
+ 10 ml 1% PVI 
Present study.  
T2 study group 12% 
PVI: Povidone-iodine. 
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4.2 Identified bacteria before prophylaxis 
 
This work showed that the most common organisms colonizing the eye were 
coagulase-negative staphylococci (CNS), 66% of all isolated bacteria in time point T0, before 
any prophylactic method. These findings are consistent with previous published studies.5;51;92 
CNS are implicated in approximately 70% of the cases of postoperative endophthalmitis.43 
The most common bacteria isolated at time point T0 from conjunctival swabs in our study 
were coagulase-negative staphylococci, S. aureus, Propionibacterium acnes and 
Corynebacterium sp. The distribution of organisms found at baseline (Table 8) was similar to 
that described in a report by Boltze et al. on normal conjunctival flora.17 An extensive 
explanation about isolated conjunctival bacteria will be presented in a separate doctoral thesis. 
 
 
4.3 Identified bacteria in treated eyes 
 
The patients with added antibiotic were observed to have a considerable reduction of 
all bacteria after the levofloxacin prophylaxis (P < 0.05). This was caused both as a result of 
decrease of staphylococci and other bacteria. The major reduction of conjunctival bacteria 
identified in both groups was observed after the povidone-iodine flushing; either diminution 
of staphylococci or other bacteria (Streptococcus sp, Corynebacterium sp and particularly 
with regard to Propionibacterium sp). The absence of Propionibacterium sp in the cultures 
from the combined therapy group coincides with the observations of Binder et al15. They 
observed the absence of growth of Propionibacterium, after the combined prophylaxis of PVI 
and antibiotic (Polymyxin B Sulfat, Neomycin sulfat and Gramicidin). They also noted, as we 
did, an important reduction of staphylococci after combined PVI and antibiotic prophylaxis. 
 
After PVI the patients from the control group experienced a reduction in the number of 
identified bacteria from 62 to 22 isolates. The patients with antibiotic had an important 
reduction, from 55 to 8 recognized bacteria after PVI. The most remarkable difference among 
results from both groups after PVI flushing corresponds to the assortment of identified 
bacteria. Patients with levofloxacin and PVI flushing had only 8 CNS; no other kind of 
bacteria was identified. Patients with PVI prophylaxis alone experienced a result (15 CNS) 
rendering almost twice as many isolated CNS than patients with combined therapy (8 CNS). 
These patients with simple prophylaxis were also discovered to have had one S. aureus, two 
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streptococci, one Gram-negative rods and three strains of Propionibacterium sp. Comparing  
these results to those reported by Binder et al15 (combined topical Polymyxin B 
Sulfat/Neomycin sulfat/Gramicidin and PVI flushing) it is revealed an incremented effect of 
combining levofloxacin and PVI flushing in decreasing bacteria other than staphylococci. 
However, in their study it was observed after the combined antibiotic therapy an 8% of 
positivity to CNS, a smaller number compared to the 12% of positive CNS in our patients, 
after combined levofloxacin and PVI. Only a comparative study could establish if that 
difference might be reproducible. 
 
 
4.4 Resistance of Staphylococcus sp to levofloxacin 
 
Unlike antiseptics such as povidone-iodine, antibiotics do not kill bacteria within 
minutes of administration, but rather require a longer period of time.20;78 The improper use of 
systemic antibiotics has caused resistance to existing agents to emerge. Topical use of 
conjunctival antibiotics is not responsible for this resistance. According to Hodge46 it is 
difficult to stay in a sub-lethal concentration in a conjunctival clinical treatment, since the 
tissue levels that can be achieved with topical dosing may be much higher than that typically 
achieved after systemic dosing. In a more recent study, Seppala et al found that the possibility 
of ocular antibiotics affecting the resistance patterns of the bacteria is unlikely.83 
 
Resistance among older fluoroquinolones has been attributed in part to inappropriate 
sublethal dosing, which has induced mutagenesis in once susceptible pathogens.59 To prevent 
further resistance and avoid infection by resistant organisms, it is necessary to consider newer 
agents such as third and fourth-generation fluoroquinolones. These agents confer a dual-
binding mechanism of action on gram-positive organisms, inhibiting both DNA gyrase and 
topoisomerase IV, which is believed to expand their spectrum of activity to inhibit bacterial 
strains otherwise resistant to older fluoroquinolones.36;64 
 
Fluoroquinolones are among the most frequently used topical antibiotics for 
endophthalmitis prophylaxis. They are bactericidal against a broad-spectrum of organisms, 
killing both Gram-positive and Gram-negative bacteria, but resistance has been emerging to 
this class of antibiotics, particularly among gram-positive organisms. Increase of resistance to 
ciprofloxacin and ofloxacin was recorded from 1993 to 1997 among S. aureus, coagulase-
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negative staphylococci, and Streptococcus species, approaching 50 % of isolates examined, 
for some species.39 A study in South Florida reported a three-fold increase in fluoroquinolone 
resistance among S. aureus isolates4 and there are also reports of resistance to first and second 
generation fluoroquinolones among Gram-negative organisms.23  
 
In our study levofloxacin presented at baseline (T0 from both groups) a Resistant Rate 
(RR) to CNS of 6.4%. This result is comparable to the study of Ta in 2003,92 who reported 
that cultured organisms were least likely to be resistant to levofloxacin. Compared with 
levofloxacin (RR of 6 %), the other fluoroquinolones ciprofloxacin (RR of 15%), ofloxacin 
(RR of 16%) and norfloxacin (RR of 15%) were associated with significantly greater rates of 
resistance.  
 
At the start of the study, before any prophylaxis (T0), the number of resistant 
staphylococci was similar in both groups, observing 3 strains of bacteria resistant in each 
group. At time point T2, after povidone-iodine flushing, we found in the control group 16 
Staphylococcus sp (one a S. aureus) and 8 in the study group. At time point T2, povidone-
iodine lowered resistant and intermediate-susceptible bacteria in both control and study 
groups (from 5 to 1 intermediate/resistant bacteria in the control group, and from 5 to 3 in the 
study group). After the PVI flushing, 2 of 8 strains were resistant in the patients under 
combined therapy with levofloxacin (20% of identified staphylococcus) and one of 15 isolates 
(6%) in the patients with only PVI flushing. 
 
One must consider the possibility that in vitro antibiotic susceptibility testing as 
performed in our study might not accurately reflect the true in vivo effectiveness of the 
antibiotics tested. The in vitro antibiotic susceptibility using the Kirby-Bauer disc diffusion 
technique is based on serum antibiotic concentration, which might be less than the 
concentration achieved with topical or subconjunctival delivery.92 The high concentration of 
commonly used antibiotics achieved with frequent topical antibiotic application or by 
subconjunctival injection might change the relative efficacy of the various agents in vivo. The 
typical concentration of topical fluoroquinolones is 3 to 5 mg/ml.92 The tear concentration 
varies, depending on the dosing regimen. Given the rise in antibiotic resistance, 
ophthalmologists must carefully choose the antibiotic that is most effective in minimizing 
ocular colonization with resistant organisms. In vitro antibiotic susceptibility testing is the 
most commonly cited standard and will continue to guide the ophthalmologist in antibiotic 
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selection. This might include choosing antibiotics that have shown the greatest effectiveness 
against bacteria in vitro, frequent dosing of an antibiotic over a short period of time rather 
than chronic use, and performing antibiotic susceptibility prevalence surveys. 
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5. Summary 
In comparison to conjunctival flushing with 10 ml 1% povidone-iodine (PVI) alone, 
adding a one day presurgical prophylactic therapy with 0.5% levofloxacin eye drops 
significantly reduces positive bacterial conjunctival cultures prior to, and upon completion of 
intraocular surgery (P = 0.008).  This is the first prospective randomized study demostrating 
an enhanced effect through a combination of a topical fluoroquinolone antibiotic along with 
PVI compared to PVI flushing alone. 
 
There are no conclusive scientific data showing that use of antibiotics reduces the risk 
of the ultimate outcome parameter: postoperative endophthalmitis.25;87 Only one prospective 
study documented efficacy in reducing endophthalmitis89, which showed that preoperative 
topical 5% povidone-iodine significantly reduced the risk of endophthalmitis. The difficulty 
to perform a prospective controlled clinical series in today’s medical-legal environment leads 
us to rely on indirect studies.  
 
 Coagulase-negative staphylococci (CNS) were the main isolated bacteria (T0) before 
any conducted prophylactic measure. Other bacteria were S. aureus, streptococci sp and 
Propionibacterium sp. Combinative prophylaxis with levofloxacin and PVI showed in 12% of 
the 66 study cultures only CNS. 24 % of the 65 patients with only PVI prophylaxis presented 
a CNS; additionally 10% of those same 65 patients presented other bacteria. These results 
parallel the findings of our positive cultures. The 6% Resistant Rate (RR) of levofloxacin to 
staphylococci at baseline (T0) is comparable to previously reported findings. 61 After PVI 
prophylaxis alone a RR to levofloxacin of 6% was seen, demostrating no change to baseline. 
 
While this study did not prove that a combination of topical 0.5% levofloxacin and 
povidone-iodine irrigation reduces the risk for postoperative endophthalmitis, the combination 
showed an enhanced effect in diminishing the conjunctival bacterial flora. As this has shown 
to be the main origin of bacteria causing post operative endophthalmitis, it can be 
hypothesized that this regime reduces the risk of intraocular contamination and consequently 
postoperative endopthalmitits. To finally clarify this issue a large prospective randomized 
multi-center clinical trial is underway.49 Until the results are published, combined prophylaxis 
with topical 0.5% levofloxacin and irrigation with povidone-iodine can be recommended in 
patients scheduled for intraocular surgery. 
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Zusammenfassung 
 
Im Vergleich mit einer alleinigen Spülung der Bindehaut mit 10ml 1%-iger Povidone-
Iod-Lösung (PVL) reduziert eine zusätzlich eintägig, präoperativ gegebene, prophylaktische 
Therapie mit 0,5%-igen Levofloxazin Augentropfen die Anzahl positiver Bakterienkulturen 
sowohl vor und direkt nach dem intraokularen Eingriff (P = 0.008). Dies ist die erste 
prospektiv randomisierte Untersuchung, welche diesen zusätzlichen Effekt einer Kombination 
aus einem topisch gegebenen Fluorochinolon Antibiotikum und einer Spülung mit PVL 
gegenüber einer alleinigen Spülung mit PVL nachweist. 
 
Es gibt keine endgültigen, wissenschaftlichen Daten, die belegen, dass eine topische, 
antibiotische Behandlung das Risiko einer postoperativen Endophthalmitis reduziert.25;87  
Eine prospektive Studie konnte dagegen für die präoperative Behandlung mit 5%-iger PVL 
ein reduziertes Risiko für eine Endophthalmitisentstehung nachweisen. 89 Die Schwierigkeit 
eine prospektiv, kontrollierte Studie zu diesem Thema unter den heute gegebenen 
medizinisch-juristischen Gegebenheiten durchzuführen, erfordert die Zuhilfenahme von 
indirekten Nachweisparametern.  
 
 Es wurden überwiegend Koagulase-negative Staphylokokken (CNS) unter den 
isolierten Bakterien zum Zeitpunkt T0, das heißt vor jedweder durchgeführten 
prophylaktischen Maßnahme, nachgewiesen. Andere nachgewiesene Bakterien waren S. 
aureus, Streptococci sp und Propionibacterium sp. Die kombinierte Behandlung mit 
Levofloxacin und PVL zeigte in 12% der 66 Studienkulturen nur CNS. In 24 % der 65 
Patienten mit alleiniger PVL Prophylaxe fanden sich CNS; zusätzlich zeigten jedoch 10% 
dieser 65 Patienten auch andere bakterielle Erregernachweise. Diese Ergebnisse gehen einher 
mit unsren Nachweisen von Positivkulturen. Die 6% Resistenzrate (RR) gegenüber 
Levofloxazin bei Staphylokokken zum Ausgangspunkt der Studie (T0) ist vergleichbar mit 
den Ergebnissen vorhergehender Studien.61 Nach alleiniger PVL Prophylaxe (T2) zeigte die 
gefundene RR von 6% gegenüber  Levofloxacin keine Veränderung of gegenüber dem 
Ausgangspunkt (T0). 
 
Obwohl diese Untersuchung nicht nachweisen konnte, dass eine kombinierte 
Behandlung mit 0,5%-igen Levofloxazin Augentropfen und Spülung der Bindehaut mit PVL 
das Risiko einer postoperativen Endophthalmitis reduziert, zeigte die sie doch, dass die 
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kombinierte Behandlung eine verbesserte Wirkung in Hinblick auf eine Reduktion der 
bakteriellen Bindehautflora besitzt. Da diese als Hauptursprungsort für eine bakterienbedingte 
Endophthalmitis gilt, lässt sich postulieren, dass dieses Behandlungsregime das Risiko einer 
intraokularen Kontamination und deshalb auch das einer postoperativen Endophthalmitis 
vermindert. Um dies jedoch endgültig zu klären wird derzeit eine groß angelegte 
Multizenterstudie durchgeführt.49 Bis deren Ergebnisse verfügbar sind, kann die kombinierte 
Behandlung mit 0,5%-igen Levofloxazin Augentropfen und Spülung der Bindehaut mit PVL 
für Patienten vor intraokularem Eingriff empfohlen werden. 
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